Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in synthetic biology, Matthew Jones is part of a team addressing this issue in an ambitious project with exciting potential.
People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.
In essence, the approach to pathology has remained unchanged for years – but is it time for pathologists to experience digital transformation powered by AI?
The ambition to reduce or eliminate single-use plastics from the world’s supply chains is of course as laudable as it is essential. A team at CC is dedicated to doing something about it – by creating a guide to help innovators switch to alternatives
Advances in drug delivery medical devices has remained constant for 30 years. But now, we are entering an exciting new era of innovation with a new generation of miniature active implantable medical devices (AIMDs) for drug delivery.
“We’re a start-up, we’ve got some great technology, but to grow we feel we need to get some digital services” Here’s a step-by-step guide to digital services